ADEA Stock Analysis: ADEIA | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 2.748m USD | 12M Return: 54.5% | US00676P1075 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.4M
EPS Trend: 52.9%
Qual. Beats: 0
Rev. Trend: 65.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Adeia Inc. is a media and semiconductor intellectual property (IP) licensing platform company that monetizes patent portfolios through royalty agreements with technology and entertainment industry customers. The IP licensing model generates revenue by allowing manufacturers and service providers to use patented technologies in exchange for ongoing fees, without the need to produce or sell physical products directly. The company operates across the United States, Asia, Canada, Europe, the Middle East, and other international markets.
Adeias licensing activities span a broad range of customer segments, including multichannel video programming distributors (cable, satellite, and telecom TV providers), over-the-top streaming services, content providers and media companies, consumer electronics manufacturers (such as smart TV, streaming device, and gaming console producers), semiconductor companies (memory, logic, sensors, and RF devices), and social media platforms. All intellectual property is licensed under the Adeia brand.
The company was formerly known as Xperi Holding Corporation before adopting the Adeia name, was incorporated in 2019, and is headquartered in San Jose, California. It trades on NASDAQ under the ticker ADEA and is classified within the Information Technology sector, reflecting its position at the intersection of media technology and semiconductor intellectual property.
- Semiconductor IP licensing revenue accelerates with memory and logic chip demand
- Major streaming and TV manufacturer license renewals drive royalty growth
- Patent litigation settlements and verdicts boost quarterly cash flow
| Net Income: 122.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 0.95 > 1.0 |
| NWC/Revenue: 43.37% < 20% (prev 47.73%; Δ -4.36% < -1%) |
| CFO/TA 0.19 > 3% & CFO 191.0m > Net Income 122.7m |
| Net Debt (267.4m) to EBITDA (261.0m): 1.02 < 3 |
| Current Ratio: 3.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (114.4m) vs 12m ago 1.98% < -2% |
| Gross Margin: 75.36% > 18% (prev 84.73%; Δ -9.37% > 0.5%) |
| Asset Turnover: 44.92% > 50% (prev 34.97%; Δ 9.95% > 0%) |
| Interest Coverage Ratio: 5.52 > 6 (EBIT TTM 199.1m / Interest Expense TTM 36.1m) |
| A: 0.20 (Total Current Assets 295.1m - Total Current Liabilities 90.9m) / Total Assets 1.01b |
| B: 0.12 (Retained Earnings 121.2m / Total Assets 1.01b) |
| C: 0.19 (EBIT TTM 199.1m / Avg Total Assets 1.05b) |
| D: 0.89 (Book Value of Equity 477.2m / Total Liabilities 536.3m) |
| Altman-Z'' = 3.92 = AA |
| DSRI: 0.87 (Receivables 147.2m/136.2m, Revenue 470.9m/378.7m) |
| GMI: 1.12 (GM 84.73% / 75.36%) |
| AQI: 0.94 (AQ_t 0.70 / AQ_t-1 0.74) |
| SGI: 1.24 (Revenue 470.9m / 378.7m) |
| TATA: -0.07 (NI 122.7m - CFO 191.0m) / TA 1.01b) |
| Beneish M = -2.89 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at USD 25.48 with a total of 770,376 shares traded. Over the past week, the price has changed by +2.66%, over one month by -6.08%, over three months by -15.97% and over the past year by +54.48%.
Current recommended Stop Loss: 23.30 (which is 8.6% or 2 ATR below the current price).
ADEIA has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy ADEA.
- StrongBuy: 1
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 43 | 68.8% |
P/E Trailing = 22.8624
P/E Forward = 15.5521
P/S = 5.8364
P/B = 5.773
P/EG = 1.5095
Revenue TTM = 470.9m USD
EBIT TTM = 199.1m USD
EBITDA TTM = 261.0m USD
Long Term Debt = 365.0m USD (from longTermDebt, last quarter)
Short Term Debt = 21.6m USD (from shortTermDebt, last quarter)
Debt = 404.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 9.25m
Net Debt = 267.4m USD (calculated: Debt 404.5m - CCE 137.1m)
Enterprise Value = 3.02b USD (2.75b + Debt 404.5m - CCE 137.1m)
Interest Coverage Ratio = 5.52 (Ebit TTM 199.1m / Interest Expense TTM 36.1m)
EV/FCF = 16.62x (Enterprise Value 3.02b / FCF TTM 181.5m)
FCF Yield = 6.02% (FCF TTM 181.5m / Enterprise Value 3.02b)
FCF Margin = 38.54% (FCF TTM 181.5m / Revenue TTM 470.9m)
Net Margin = 26.05% (Net Income TTM 122.7m / Revenue TTM 470.9m)
Gross Margin = 75.36% ((Revenue TTM 470.9m - Cost of Revenue TTM 116.0m) / Revenue TTM)
Gross Margin QoQ = 26.40% (prev 84.33%)
Tobins Q-Ratio = 2.98 (Enterprise Value 3.02b / Total Assets 1.01b)
Interest Expense / Debt = 8.92% (Interest Expense 36.1m / Debt 404.5m)
Taxrate = 26.27% (43.7m / 166.4m)
NOPAT = 146.8m (EBIT 199.1m * (1 - 26.27%))
Current Ratio = 3.25 (Total Current Assets 295.1m / Total Current Liabilities 90.9m)
Debt / Equity = 0.85 (Debt 404.5m / totalStockholderEquity, last quarter 477.2m)
Debt / EBITDA = 1.02 (Net Debt 267.4m / EBITDA 261.0m)
Debt / FCF = 1.47 (Net Debt 267.4m / FCF TTM 181.5m)
Total Stockholder Equity = 459.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.70% (Net Income 122.7m / Total Assets 1.01b)
RoE = 26.70% (Net Income TTM 122.7m / Total Stockholder Equity 459.5m)
RoCE = 24.15% (EBIT 199.1m / Capital Employed (Equity 459.5m + L.T.Debt 365.0m))
RoIC = 15.95% (NOPAT 146.8m / Invested Capital 920.7m)
WACC = 12.99% (E(2.75b)/V(3.15b) * Re(13.93%) + D(404.5m)/V(3.15b) * Rd(8.92%) * (1-Tc(0.26)))
Discount Rate = 13.93% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 53.84 | Cagr: 0.56%
[DCF] Terminal Value 60.79% ; FCFF base≈182.4m ; Y1≈181.3m ; Y5≈188.3m
[DCF] Fair Price = 12.49 (EV 1.64b - Net Debt 267.4m = Equity 1.38b / Shares 110.3m; r=12.99% [WACC]; 5y FCF grow -1.17% → 2.50% )
EPS Correlation: 52.94 | EPS CAGR: 10.55% | SUE: 0.42 | # QB: 0
Revenue Correlation: 65.44 | Revenue CAGR: 7.72% | SUE: -0.06 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.30 | Chg30d=+0.00% | Revisions=-50% | Analysts=4
EPS current Year (2026-12-31): EPS=1.42 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=-13.7% | GrowthRev=-6.2%
EPS next Year (2027-12-31): EPS=1.60 | Chg30d=-0.62% | Revisions=+0% | GrowthEPS=+12.4% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: -30% (up=2, down=5)